MA39354A1 - Compositions and methods for modulating complement factor b expression - Google Patents
Compositions and methods for modulating complement factor b expressionInfo
- Publication number
- MA39354A1 MA39354A1 MA39354A MA39354A MA39354A1 MA 39354 A1 MA39354 A1 MA 39354A1 MA 39354 A MA39354 A MA 39354A MA 39354 A MA39354 A MA 39354A MA 39354 A1 MA39354 A1 MA 39354A1
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- expression
- methods
- complement factor
- modulating complement
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne des procédés, des composés et des compositions permettant de traiter, prévenir ou améliorer les symptômes d'une maladie associée à la dérégulation de la voie d'activation alterne du complément par l'administration d'un inhibiteur spécifique du facteur b du complément (cfb) à un sujet.The present invention provides methods, compounds and compositions for treating, preventing or ameliorating the symptoms of a disease associated with deregulation of the alternative complement activation pathway by administration of a specific factor b inhibitor. complement (cfb) to a subject.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461987471P | 2014-05-01 | 2014-05-01 | |
PCT/US2015/028916 WO2015168635A2 (en) | 2014-05-01 | 2015-05-01 | Compositions and methods for modulating complement factor b expression |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39354A1 true MA39354A1 (en) | 2018-06-29 |
Family
ID=63586932
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA46307A MA46307B1 (en) | 2014-05-01 | 2015-05-01 | Composition and methods for modulating expression of complement factor b |
MA39354A MA39354A1 (en) | 2014-05-01 | 2015-05-01 | Compositions and methods for modulating complement factor b expression |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA46307A MA46307B1 (en) | 2014-05-01 | 2015-05-01 | Composition and methods for modulating expression of complement factor b |
Country Status (1)
Country | Link |
---|---|
MA (2) | MA46307B1 (en) |
-
2015
- 2015-05-01 MA MA46307A patent/MA46307B1/en unknown
- 2015-05-01 MA MA39354A patent/MA39354A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA46307A1 (en) | 2021-04-30 |
MA46307B1 (en) | 2021-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA38959A1 (en) | Modulators of complement factor b | |
MA43518A (en) | 3-AZABICYCLO [3.1.0] SUBSTITUTED HEXANES SERVING AS KETOHEXOKINASE INHIBITORS | |
BR112018004620A2 (en) | kras expression modulators | |
EA201692204A1 (en) | COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR | |
EA201692201A1 (en) | CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7 | |
MX2020012165A (en) | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer. | |
GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
BR112018005223A2 (en) | compounds and methods for modulating angiotensinogen expression | |
MX2018002049A (en) | Diacerein or its analogs for inhibiting expression of asc, nlrp3, and/or formation of nlrp3 inflammasome complex. | |
EA201692177A1 (en) | CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7 | |
MA40240A (en) | HETERARYL KINASE INHIBITION COMPOUNDS | |
BR112017028194A2 (en) | diaciglycerol acyltransferase 2 modulators (dgat2) | |
EA201791096A1 (en) | 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS GPR139 MODULATORS | |
EA201791711A1 (en) | ANTIBODIES TO TRANSTIRETIN | |
EA201791710A1 (en) | ANTIBODIES TO TRANSTIRETIN | |
MA34968B1 (en) | ASYMMETRIC UREA AND MEDICAL USES THEREOF | |
EA201992248A1 (en) | ANTI-C5a-ANTIBODIES AND THEIR APPLICATION | |
MX2023008839A (en) | Methods of treating irritable bowel syndrome with modified or delayed release formulations of linaclotide. | |
EA201791450A1 (en) | 3,5-DIAMINOPYRAZOLES KINASE INHIBITORS | |
MY191993A (en) | Use of isolated fractions of mastic gum for treating optic neuropathy | |
MA39354A1 (en) | Compositions and methods for modulating complement factor b expression | |
MA43165B1 (en) | RET INHIBITORS | |
EA201990671A1 (en) | MUTANT ISOCITRATE DEHYDROGENASE INHIBITORS AND INCLUDING THEIR COMPOSITIONS AND METHODS | |
EA201990393A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING MASP-3 USED FOR TREATING VARIOUS DISEASES AND DISORDERS | |
CR20190329A (en) | MODULATORS OF COMPLEMENT FACTOR Bi |